Report Ocean | Market Research Report | Industry Analysis | Market Trends | Forecasting
 SALES@REPORTOCEAN.COM
 +1 888 212 3539 (US - TOLL FREE)    +91 999 711 2116 (REST OF WORLD)

`
Global Therapeutic Nuclear Medicines Market Growth 2019-2024

Global Therapeutic Nuclear Medicines Market Growth 2019-2024

Published date: 07-05-2019  Region: Global  Pages: 165  Format: Pdf  Publisher Name: LPI(LP Information)
SKU: RO1/109/3526

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
North Americas is the largest consumption place, with a revenue market share nearly 44.8% in 2018. Following North Americas, Europe is the second largest consumption place with the revenue market share of 29% in 2018.

According to this study, over the next five years the Therapeutic Nuclear Medicines market will register a 18.7% CAGR in terms of revenue, the global market size will reach US$ 1968.7 million by 2024, from US$ 836.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Therapeutic Nuclear Medicines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.

This study considers the Therapeutic Nuclear Medicines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Radium-223
Lutetium-177
Iodine-131
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Thyroid
Bone Metastasis
Lymphoma
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Therapeutic Nuclear Medicines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Therapeutic Nuclear Medicines market by identifying its various subsegments.
Focuses on the key global Therapeutic Nuclear Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Therapeutic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Therapeutic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Therapeutic Nuclear Medicines Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Therapeutic Nuclear Medicines Consumption 2014-2024
2.1.2 Therapeutic Nuclear Medicines Consumption CAGR by Region
2.2 Therapeutic Nuclear Medicines Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Nuclear Medicines Consumption by Type
2.3.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2014-2019)
2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
2.3.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2014-2019)
2.4 Therapeutic Nuclear Medicines Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Nuclear Medicines Consumption by Application
2.5.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)
2.5.2 Global Therapeutic Nuclear Medicines Value and Market Share by Application (2014-2019)
2.5.3 Global Therapeutic Nuclear Medicines Sale Price by Application (2014-2019)

3 Global Therapeutic Nuclear Medicines by Manufacturers
3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers
3.1.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2019)
3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2017-2019)
3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers
3.2.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2019)
3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Therapeutic Nuclear Medicines Sale Price by Manufacturers
3.4 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Therapeutic Nuclear Medicines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Therapeutic Nuclear Medicines by Regions
4.1 Therapeutic Nuclear Medicines by Regions
4.1.1 Global Therapeutic Nuclear Medicines Consumption by Regions
4.1.2 Global Therapeutic Nuclear Medicines Value by Regions
4.2 Americas Therapeutic Nuclear Medicines Consumption Growth
4.3 APAC Therapeutic Nuclear Medicines Consumption Growth
4.4 Europe Therapeutic Nuclear Medicines Consumption Growth
4.5 Middle East & Africa Therapeutic Nuclear Medicines Consumption Growth

5 Americas
5.1 Americas Therapeutic Nuclear Medicines Consumption by Countries
5.1.1 Americas Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
5.1.2 Americas Therapeutic Nuclear Medicines Value by Countries (2014-2019)
5.2 Americas Therapeutic Nuclear Medicines Consumption by Type
5.3 Americas Therapeutic Nuclear Medicines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Therapeutic Nuclear Medicines Consumption by Countries
6.1.1 APAC Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
6.1.2 APAC Therapeutic Nuclear Medicines Value by Countries (2014-2019)
6.2 APAC Therapeutic Nuclear Medicines Consumption by Type
6.3 APAC Therapeutic Nuclear Medicines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Therapeutic Nuclear Medicines by Countries
7.1.1 Europe Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
7.1.2 Europe Therapeutic Nuclear Medicines Value by Countries (2014-2019)
7.2 Europe Therapeutic Nuclear Medicines Consumption by Type
7.3 Europe Therapeutic Nuclear Medicines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Therapeutic Nuclear Medicines by Countries
8.1.1 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Therapeutic Nuclear Medicines Value by Countries (2014-2019)
8.2 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Type
8.3 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Therapeutic Nuclear Medicines Distributors
10.3 Therapeutic Nuclear Medicines Customer

11 Global Therapeutic Nuclear Medicines Market Forecast
11.1 Global Therapeutic Nuclear Medicines Consumption Forecast (2019-2024)
11.2 Global Therapeutic Nuclear Medicines Forecast by Regions
11.2.1 Global Therapeutic Nuclear Medicines Forecast by Regions (2019-2024)
11.2.2 Global Therapeutic Nuclear Medicines Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Therapeutic Nuclear Medicines Forecast by Type
11.8 Global Therapeutic Nuclear Medicines Forecast by Application

12 Key Players Analysis
12.1 Bayer
12.1.1 Company Details
12.1.2 Therapeutic Nuclear Medicines Product Offered
12.1.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bayer News
12.2 Novartis AG
12.2.1 Company Details
12.2.2 Therapeutic Nuclear Medicines Product Offered
12.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Novartis AG News
12.3 China Isotope & Radiation
12.3.1 Company Details
12.3.2 Therapeutic Nuclear Medicines Product Offered
12.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 China Isotope & Radiation News
12.4 Dongcheng
12.4.1 Company Details
12.4.2 Therapeutic Nuclear Medicines Product Offered
12.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Dongcheng News
12.5 Q BioMed
12.5.1 Company Details
12.5.2 Therapeutic Nuclear Medicines Product Offered
12.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Q BioMed News
12.6 Curium Pharmaceuticals
12.6.1 Company Details
12.6.2 Therapeutic Nuclear Medicines Product Offered
12.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Curium Pharmaceuticals News
12.7 Jubilant DraxImage
12.7.1 Company Details
12.7.2 Therapeutic Nuclear Medicines Product Offered
12.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Jubilant DraxImage News
12.8 Lantheus
12.8.1 Company Details
12.8.2 Therapeutic Nuclear Medicines Product Offered
12.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Lantheus News
12.9 Spectrum Pharmaceuticals
12.9.1 Company Details
12.9.2 Therapeutic Nuclear Medicines Product Offered
12.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Spectrum Pharmaceuticals News
12.10 Progenics Pharmaceuticals
12.10.1 Company Details
12.10.2 Therapeutic Nuclear Medicines Product Offered
12.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Progenics Pharmaceuticals News
12.11 International Isotopes

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Therapeutic Nuclear Medicines
Table Product Specifications of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Report Years Considered
Figure Market Research Methodology
Figure Global Therapeutic Nuclear Medicines Consumption Growth Rate 2014-2024 (K Units)
Figure Global Therapeutic Nuclear Medicines Value Growth Rate 2014-2024 ($ Millions)
Table Therapeutic Nuclear Medicines Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Radium-223
Table Major Players of Radium-223
Figure Product Picture of Lutetium-177
Table Major Players of Lutetium-177
Figure Product Picture of Iodine-131
Table Major Players of Iodine-131
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2014-2019)
Table Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Table Global Therapeutic Nuclear Medicines Revenue by Type (2014-2019) ($ million)
Table Global Therapeutic Nuclear Medicines Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Therapeutic Nuclear Medicines Value Market Share by Type (2014-2019)
Table Global Therapeutic Nuclear Medicines Sale Price by Type (2014-2019)
Figure Therapeutic Nuclear Medicines Consumed in Thyroid
Figure Global Therapeutic Nuclear Medicines Market: Thyroid (2014-2019) (K Units)
Figure Global Therapeutic Nuclear Medicines Market: Thyroid (2014-2019) ($ Millions)
Figure Therapeutic Nuclear Medicines Consumed in Bone Metastasis
Figure Global Therapeutic Nuclear Medicines Market: Bone Metastasis (2014-2019) (K Units)
Figure Global Therapeutic Nuclear Medicines Market: Bone Metastasis (2014-2019) ($ Millions)
Figure Therapeutic Nuclear Medicines Consumed in Lymphoma
Figure Global Therapeutic Nuclear Medicines Market: Lymphoma (2014-2019) (K Units)
Figure Global Therapeutic Nuclear Medicines Market: Lymphoma (2014-2019) ($ Millions)
Figure Therapeutic Nuclear Medicines Consumed in Other
Figure Global Therapeutic Nuclear Medicines Market: Other (2014-2019) (K Units)
Figure Global Therapeutic Nuclear Medicines Market: Other (2014-2019) ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Table Global Therapeutic Nuclear Medicines Value by Application (2014-2019)
Table Global Therapeutic Nuclear Medicines Value Market Share by Application (2014-2019)
Figure Global Therapeutic Nuclear Medicines Value Market Share by Application (2014-2019)
Table Global Therapeutic Nuclear Medicines Sale Price by Application (2014-2019)
Table Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2019) (K Units)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2017-2019)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers in 2017
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers in 2018
Table Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2019) ($ Millions)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2019)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers in 2017
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers in 2018
Table Global Therapeutic Nuclear Medicines Sale Price by Manufacturers (2017-2019)
Figure Global Therapeutic Nuclear Medicines Sale Price by Manufacturers in 2018
Table Global Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Manufacturers
Table Players Therapeutic Nuclear Medicines Products Offered
Table Therapeutic Nuclear Medicines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Therapeutic Nuclear Medicines Consumption by Regions 2014-2019 (K Units)
Table Global Therapeutic Nuclear Medicines Consumption Market Share by Regions 2014-2019
Figure Global Therapeutic Nuclear Medicines Consumption Market Share by Regions 2014-2019
Table Global Therapeutic Nuclear Medicines Value by Regions 2014-2019 ($ Millions)
Table Global Therapeutic Nuclear Medicines Value Market Share by Regions 2014-2019
Figure Global Therapeutic Nuclear Medicines Value Market Share by Regions 2014-2019
Figure Americas Therapeutic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure Americas Therapeutic Nuclear Medicines Value 2014-2019 ($ Millions)
Figure APAC Therapeutic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure APAC Therapeutic Nuclear Medicines Value 2014-2019 ($ Millions)
Figure Europe Therapeutic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure Europe Therapeutic Nuclear Medicines Value 2014-2019 ($ Millions)
Figure Middle East & Africa Therapeutic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure Middle East & Africa Therapeutic Nuclear Medicines Value 2014-2019 ($ Millions)
Table Americas Therapeutic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table Americas Therapeutic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure Americas Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2018
Table Americas Therapeutic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table Americas Therapeutic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure Americas Therapeutic Nuclear Medicines Value Market Share by Countries in 2018
Table Americas Therapeutic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table Americas Therapeutic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Americas Therapeutic Nuclear Medicines Consumption Market Share by Type in 2018
Table Americas Therapeutic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table Americas Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Americas Therapeutic Nuclear Medicines Consumption Market Share by Application in 2018
Figure United States Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure United States Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Canada Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Canada Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Mexico Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Mexico Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table APAC Therapeutic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table APAC Therapeutic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure APAC Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2018
Table APAC Therapeutic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table APAC Therapeutic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure APAC Therapeutic Nuclear Medicines Value Market Share by Countries in 2018
Table APAC Therapeutic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table APAC Therapeutic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure APAC Therapeutic Nuclear Medicines Consumption Market Share by Type in 2018
Table APAC Therapeutic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table APAC Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure APAC Therapeutic Nuclear Medicines Consumption Market Share by Application in 2018
Figure China Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure China Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Japan Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Japan Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Korea Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Korea Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Southeast Asia Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure India Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure India Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Australia Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Australia Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table Europe Therapeutic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table Europe Therapeutic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure Europe Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2018
Table Europe Therapeutic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table Europe Therapeutic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure Europe Therapeutic Nuclear Medicines Value Market Share by Countries in 2018
Table Europe Therapeutic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table Europe Therapeutic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Europe Therapeutic Nuclear Medicines Consumption Market Share by Type in 2018
Table Europe Therapeutic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table Europe Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Europe Therapeutic Nuclear Medicines Consumption Market Share by Application in 2018
Figure Germany Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Germany Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure France Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure France Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure UK Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure UK Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Italy Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Italy Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Russia Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Russia Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Spain Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Spain Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Therapeutic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2018
Table Middle East & Africa Therapeutic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Therapeutic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Therapeutic Nuclear Medicines Value Market Share by Countries in 2018
Table Middle East & Africa Therapeutic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Type in 2018
Table Middle East & Africa Therapeutic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Share by Application in 2018
Figure Egypt Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Egypt Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure South Africa Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure South Africa Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Israel Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Israel Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Turkey Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Turkey Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Therapeutic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure GCC Countries Therapeutic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table Therapeutic Nuclear Medicines Distributors List
Table Therapeutic Nuclear Medicines Customer List
Figure Global Therapeutic Nuclear Medicines Consumption Growth Rate Forecast (2019-2024) (K Units)
Figure Global Therapeutic Nuclear Medicines Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Therapeutic Nuclear Medicines Consumption Forecast by Countries (2019-2024) (K Units)
Table Global Therapeutic Nuclear Medicines Consumption Market Forecast by Regions
Table Global Therapeutic Nuclear Medicines Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Therapeutic Nuclear Medicines Value Market Share Forecast by Regions
Figure Americas Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Americas Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure APAC Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure APAC Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Europe Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Europe Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Middle East & Africa Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Middle East & Africa Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure United States Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure United States Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Canada Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Canada Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Mexico Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Mexico Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Brazil Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Brazil Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure China Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure China Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Japan Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Japan Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Korea Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Korea Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Southeast Asia Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Southeast Asia Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure India Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure India Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Australia Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Australia Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Germany Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Germany Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure France Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure France Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure UK Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure UK Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Italy Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Italy Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Russia Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Russia Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Spain Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Spain Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Egypt Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Egypt Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure South Africa Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure South Africa Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Israel Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Israel Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Turkey Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Turkey Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure GCC Countries Therapeutic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure GCC Countries Therapeutic Nuclear Medicines Value 2019-2024 ($ Millions)
Table Global Therapeutic Nuclear Medicines Consumption Forecast by Type (2019-2024) (K Units)
Table Global Therapeutic Nuclear Medicines Consumption Market Share Forecast by Type (2019-2024)
Table Global Therapeutic Nuclear Medicines Value Forecast by Type (2019-2024) ($ Millions)
Table Global Therapeutic Nuclear Medicines Value Market Share Forecast by Type (2019-2024)
Table Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2019-2024) (K Units)
Table Global Therapeutic Nuclear Medicines Consumption Market Share Forecast by Application (2019-2024)
Table Global Therapeutic Nuclear Medicines Value Forecast by Application (2019-2024) ($ Millions)
Table Global Therapeutic Nuclear Medicines Value Market Share Forecast by Application (2019-2024)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bayer Therapeutic Nuclear Medicines Market Share (2017-2019)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Novartis AG Therapeutic Nuclear Medicines Market Share (2017-2019)
Table China Isotope & Radiation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure China Isotope & Radiation Therapeutic Nuclear Medicines Market Share (2017-2019)
Table Dongcheng Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Dongcheng Therapeutic Nuclear Medicines Market Share (2017-2019)
Table Q BioMed Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Q BioMed Therapeutic Nuclear Medicines Market Share (2017-2019)
Table Curium Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Curium Pharmaceuticals Therapeutic Nuclear Medicines Market Share (2017-2019)
Table Jubilant DraxImage Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Jubilant DraxImage Therapeutic Nuclear Medicines Market Share (2017-2019)
Table Lantheus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Lantheus Therapeutic Nuclear Medicines Market Share (2017-2019)
Table Spectrum Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Market Share (2017-2019)
Table Progenics Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Progenics Pharmaceuticals Therapeutic Nuclear Medicines Market Share (2017-2019)
Table International Isotopes Basic Information, Manufacturing Base, Sales Area and Its Competitors

All Fields are mandatory*

Name: *
Email Id: *
Job Title: *
Company: *
Phone: *
Country: *
Message: *

PLEASE SELECT A LICENSE TYPE

Related Reports